FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Clonazepam Tablets Recall

Clonazepam Tablets, USP, 0

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class III
Reported by FDA
Feb 10, 2016
Recall ID
D-0650-2016
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Clonazepam Tablets starting Jan 28, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0650-2016 on Feb 10, 2016. Reason: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.

Product description

Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21

Lot numbers, UPCs & expiration codes

Lot # 3063759, Exp.07/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0650-2016
Classification
Class III
Status
Terminated
Recall initiated
Jan 28, 2016
FDA report date
Feb 10, 2016
Quantity
868 unit cartons (86,800 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-0650-2016, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
73170
Address
1718 Northrock Ct
Code information
Lot # 3063759, Exp.07/16
Postal code
61103-1201
Report date
Feb 10, 2016
Product type
Drugs
Recall number
D-0650-2016
Classification
Class III
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
868 unit cartons (86,800 tablets)
Termination date
Dec 21, 2016
Reason for recall
Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21
Distribution pattern
Nationwide
Recall initiation date
Jan 28, 2016
Initial firm notification
Letter
Center classification date
Feb 2, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0650-2016, published Feb 10, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls